Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients

Stroke

Volumn 27, Issue 3, 1996, Pages 455-460

  Hesse, S ^a,c   Krajnik, J ^b   Luecke, D ^a   Jahnke, M T ^a   Gregoric, M ^b   Mauritz, K H ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY REHABILITATION INSTITUTE   (Slovenia)

^c Klinik Berlin   (Germany)

Author keywords

botulinum toxins; gait; hemiplegia; muscle spasticity; rehabilitation

Indexed keywords

BOTULINUM TOXIN;

ADULT; AGED; ARTICLE; ELECTROMYOGRAPHY; FEMALE; GAIT; HEMIPARESIS; HEMIPLEGIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE CONTRACTION; MUSCLE REFLEX; MUSCLE STRETCHING; PRIORITY JOURNAL; SOLEUS MUSCLE; SPASTICITY;

EID: 0030001873     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.3.455     Document Type: Article

References (18)

1. Das TK, Park DM. Botulinum toxin in treating spasticity. Br J Clin Pract. 1989;43:401-402.
2. Dengler R, Neyer U, Wolfarth K, Bettig U, Janzik HH. Local botulinum toxin in the treatment of spastic drop foot. J Neurol. 1992;239:375-378.
3. Hesse S, Friedrich H, Domasch C, Mauritz KH. Botulinum toxin therapy for upper limb flexor spasticity: preliminary results. J Rehabil Sci. 1992;5:98-101.
4. Hesse S, Lücke D, Malezic M, Bertelt C, Friedrich H, Gregoric M, Mauritz KH. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry. 1994;57:1321-1324.
5. Dunne JW, Heye N, Dunne SL. Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psychiatry. 1995; 58:232-235.
6. Grazko MA, Polo KB, Bahaman J. Botulinum toxin A for spasticity, muscle spasms and rigidity. Neurology. 1995;45:712-717.
7. Perry J, Waters RL, Perrin T. Electromyographic analysis of equinovarus following stroke. Clin Orthop. 1978;131:47-53.
8. Brunt D, Scarborough N. Ankle muscle activity during gait in children with cerebral palsy and equinovarus deformity. Arch Phys Med Rehabil. 1988;69:115-117.
9. Perry J. Gait Analysis. Thorofare, NJ: Slack Inc; 1992:312-327.
10. Knuttson E, Richards C. Different types of disturbed motor control in gait of hemiparetic patients. Brain. 1979;102:405-430.
11. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth spastic scale of muscle spasticity. Phys Ther. 1987;67: 206-207.
12. Lincoln N, Leadbitter D. Assessment of motor function in stroke patients. Physiotherapy. 1979;65:48-51.
13. Collen FM, Wade DT, Bradshaw CM. Mobility after stroke: reliability of measures of impairment and disability. Int Disabil Stud. 1990;12:6-9.
14. Manni E, Bagolini B, Petrossi VE, Errico P. Effect of botulinum toxin on extraocular muscle proprioception. Doc Ophthalmol. 1989; 72:189-198.
15. Filippi GM, Errico P, Santarelli R, Bagolini B, Manni E. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol (Stockh). 1993;113:400-404.
16. Mikhailov VV, Mikhailov VV. Effects of pathogenic action of botulinus toxin on spinal motoneurons of various types. Bull Exp Biol Med. 1976;80:1288-1290.
17. Wiegand H, Wellhöner HH. The action of botulinum A neurotoxin on the inhibition of the antidromic stimulation of the lumbar monosynaptic reflex. Naunyn Schmiedebergs Arch Pharmacol. 1977;298: 235-238.
18. Thilmann AF, Fellows SJ, Garms E. The mechanism of spastic muscle hypertonus. Brain. 1991;114:233-244.